XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Equity incentive plan
6 Months Ended
Apr. 30, 2021
Share-based Payment Arrangement [Abstract]  
Equity incentive plan

Note 13 – Equity incentive plan:

On September 4, 2014, the Board approved the grant of an aggregate of 246,000 non-qualified share options under FREIT’s Equity Incentive Plan (“the Plan”) to certain FREIT executive officers, the members of the Board and certain employees of Hekemian & Co., Inc., FREIT’s managing agent. The options have an exercise price of $18.45 per share, fully vested on September 3, 2019 and will expire 10 years from the date of grant, which will be September 3, 2024.

On November 10, 2016, the Board approved the grant of an aggregate of 38,000 non-qualified share options under the Plan to two members of the Board who were appointed to the Board during Fiscal 2016. The options have an exercise price of $21.00 per share, will vest in equal annual installments over a 5-year period and will expire 10 years from the date of grant, which will be November 9, 2026.

On May 3, 2018, the Board approved the grant of an aggregate of 38,000 non-qualified share options under the Plan to two members of the Board who were appointed to the Board during Fiscal 2018. The options have an exercise price of $15.50 per


Page 17

share, will vest in equal annual installments over a 5-year period and will expire 10 years from the date of grant, which will be May 2, 2028.

On March 4, 2019, the Board approved the grant of an aggregate of 5,000 non-qualified share options under the Plan to the Chairman of the Board. The options have an exercise price of $15.00 per share, will vest in equal annual installments over a 5-year period and will expire 10 years from the date of grant, which will be March 3, 2029.

As of April 30, 2021, 442,060 shares are available for issuance under the Plan.

The following table summarizes stock option activity for the six month periods ended April 30, 2021 and 2020:

Six Months Ended

April 30, 2021

Six Months Ended

April 30, 2020

No. of Options

Exercise

No. of Options

Exercise

Outstanding

Price

Outstanding

Price

Options outstanding at beginning of period

310,740

$

18.35

310,740

$

18.35

Options granted during period

-

-

-

-

Options forfeited/cancelled during period

-

-

-

-

Options outstanding at end of period

310,740

$

18.35

310,740

$

18.35

Options vested and expected to vest

308,310

308,310

Options exercisable at end of period

277,340

261,140

For the six month periods ended April 30, 2021 and 2020, compensation expense related to stock options vested amounted to approximately $24,000 and $24,000, respectively. At April 30, 2021, there was approximately $48,000 of unrecognized compensation cost relating to outstanding non-vested stock options to be recognized over the remaining weighted average vesting period of approximately 1.8 years.

The aggregate intrinsic value of options vested and expected to vest and options exercisable at April 30, 2021 was approximately $115,000 and $47,000, respectively.